• Home
  • Contact
  • Search

Search form

  • Competences
  • Platforms
    • Antibiotics
    • Biocatalysis and Biosynthesis
    • Bioresource Technologies
    • In Vitro Diagnostics
    • Personalized Medicine
    • Single-Use-Technology
    • TEDD Tissue Engineering for DD
    • Training for Pharma/Biotech
    • Translational and Clinical Bio-Manufacturing
  • Research and Development
    • Projects
    • Working with the Network
  • Services
    • Consulting Services
    • Working with the Network
  • Organisation
    • Members
    • Associated Members
    • Advisory Council
    • Joining the network
    • History
    • Organigramm
    • Forms
  • Events/News
    • Events
    • News
    • Galleries
  • Antibiotics
  • Biocatalysis and Biosynthesis
  • Bioresource Technologies
  • In Vitro Diagnostics
  • Personalized Medicine
  • Single-Use-Technology
  • TEDD Tissue Engineering for DD
  • Training for Pharma/Biotech
  • Translational and Clinical Bio-Manufacturing

biotechnet newsletter

Stay informed on our latest news!

Translational and Clinical Bio-Manufacturing

1. History and mission

In May 25 2018 a new Swiss-wide platform has been founded (see chapter 2) with the name "Translational and Clinical Bio-Manufacturing (TCBM)", which is affiliated with NTN biotechnet. The main objective of the TCBM platform is to foster exchange and collaborations between academic groups using and operating cleanrooms including bio-manufacturing products for translational clinical trials and/or standard therapies. The goal is to bundle the existing knowledge of experts in the area of compliant bio-manufacturing in order to optimise production processes (e.g. under "Good Manufacturing Practice" (GMP), ISO and/or FACT-JACIE) within an academic setting. For more information please see TCBM guidelines.

2. Platform founder and member organisations

The following five academic groups from all seven Swiss universities, from university hospitals and from the Swiss Federal Institute of Technology in Zurich contributed to its foundation in May 25 2018:

  • Basel Network
  • SCRM Platform Bern
  • University of Fribourg
  • SICT Foundation
  • Wyss Zurich

The steering committee (also forming the current members) of the Swiss wide TCBM platform:

  • Dr. Marie-Noelle GIRAUD (delegate), University of Fribourg and Dr. Lavinia ALBERI AUBER (deputy) SICHH.
  • Dr. MD Marisa JACONI (delegate) University of Geneva/SICT and Dr. Jean-François BRUNET (deputy), CHUV Lausanne/SICT
  • Prof. Eliane J. MULLER (delegate) University of Bern and  Prof. Gabriela M. BAERLOCHER (deputy), Insel University Hospital
  • Dr. Paul ZAJAC (delegate), ETH-Zurich/University of Basel and Dr. Alessia BOTTOS (deputy), University Hospital Basel /Basel GMP Network

The TCBM Platform is led jointly by the members of the Steering Committee and coordinated (period 2018-2021) by Prof. Eliane J. Muller (SCRM Bern)

3. How to become a TCBM platform member

To become a TCBM-platform partner, please contact: René Aeberhard, TCBM office, Murtenstrasse 40, 3008 Bern, phone: +41 31 632 79 12, e-mail: rene.aeberhard(at)dbmr.unibe.ch

The partnership fees are (p.a.): academy CHF 1'000; spin-off company CHF 1'500.- and for industry CHF 3'000.-

4. Events and News

Please visit events and news on this homepage

 

  • Antibiotics
  • Biocatalysis and Biosynthesis
  • Bioresource Technologies
  • In Vitro Diagnostics
  • Personalized Medicine
  • Single-Use-Technology
  • TEDD Tissue Engineering for DD
  • Training for Pharma/Biotech
  • Translational and Clinical Bio-Manufacturing

biotechnet newsletter

Stay informed on our latest news!

© 2016 biotechnet Switzerland
  • Impressum
  • Login